REQUEST A DEMO
Total
USD $0.00
Search more companies

Andros Pharmaceuticals Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Andros Pharmaceuticals Co., Ltd. Profile Updated: July 09, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Andros Pharmaceuticals Co., Ltd. is a biopharmaceutical company engaged in developing novel drug delivery platform technologies. The company’s main products include pain management, DNA repair, and gene therapy. The company was established in 2008 and is headquartered in Hsinchu county, Taiwan.

Headquarters
6F.,No22,Sec.2,Sheng Yi Rd, Zhubei City
Hsinchu City; Hsinchu City;

Contact Details: Purchase the Andros Pharmaceuticals Co., Ltd. report to view the information.

Website: http://www.androspharma.com

Basic Information
Total Employees:
Purchase the Andros Pharmaceuticals Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Andros Pharmaceuticals Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Andros Pharmaceuticals Co., Ltd. report to view the information.
Incorporation Date:
July 21, 2008
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
13.59%
Purchase this report to view the information.
7.31%
Purchase this report to view the information.
3.66%
Purchase this report to view the information.
1.06%
Purchase this report to view the information.
Subsidiaries
Andros Pharmaceuticals Pty Ltd. (Australia)
100%
Company Performance
Financial values in the chart are available after Andros Pharmaceuticals Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-83.98%
Total operating revenue
-83.98%
Operating profit (EBIT)
-42.55%
EBITDA
-66.44%
Net Profit (Loss) for the Period
-32.52%
Total assets
59.19%
Total equity
71.76%
Operating Profit Margin (ROS)
-45757.58%
Net Profit Margin
-38431.09%
Return on Equity (ROE)
2.19%
Quick Ratio
9.46%
Cash Ratio
5.95%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?